Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-Blind Placebo-Controlled Trial of Phloroglucinol in Irritable Bowel Syndrome
KCT0000494Phase 4Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Phloroglucinol with Placebo (2 arms). Started Sep 2009; status: completed.
02
Drugs
phloroglucinol
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on KCT0000494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000494.